Expert: ‘Covid-19 medicine is a backup weapon for vaccines’

Expert: 'Covid-19 medicine is a backup weapon for vaccines' 9
Expert: 'Covid-19 medicine is a backup weapon for vaccines' 9

One year after the Covid-19 vaccine created hope for an end to the pandemic, scientists announced the results of testing two potential antiviral pills, significantly reducing the risk of hospitalization and death.

If approved, paxlovid from Pfizer and molnupiravir from Merck will become the first two pills to treat Covid-19 from the early stages in just 5 days, when the patient has just shown symptoms.

However, experts are concerned that the community puts too much hope in medicine, thereby ignoring the inevitable rule `prevention is better than cure`.

`We will need to combine many methods if we want to successfully go upstream, instead of just trying to treat critically ill patients,` said Dr. David Boulware, Department of Infectious Diseases, University of Minnesota Medical School.

Medicine taken at home to reduce the risk of hospitalization is a turning point in the fight against the epidemic.

Initially, the drug was prescribed for people at risk of severe nCoV infection due to age or other factors.

Both oral medications are effective, but have some limitations.

Over time, experts learned not to underestimate the virus.

`Always stay optimistic with the new strategy that comes with it. I’m optimistic that we have a new cure against the disease, but also cautious that this is just an option. It only works if

Pfizer’s paxlovid drug is produced at a factory in the city of Freiburg, Germany, on November 16.

Carl Dieffenbach, Director of the Division of AIDS Research at the US National Institutes of Health, has spent decades fighting the HIV virus.

Mr. Dieffenbach believes that the world needs to have a similar view with Covid-19.

According to Dieffenbach, it is necessary to attack Covid-19 from all three angles, while also having a backup and combination plan in case the virus mutates and becomes resistant to individual drugs.

`A minimum of 6 treatments are needed. The more the better, 9 or 12 are fine. Companies can produce drugs on a large scale, readily available like aspirin or Tylenol,` he said.

Both Pfizer and Merck began scaling up production before approval.

Once there is a medicine, the world also needs to adjust to adapt.

`In the future, people may not need to see a doctor if they have symptoms (suspected of Covid-19). You can quickly test at home, then go buy medicine or have medicine available to use immediately.`

Some scientists worry that people will use the drug as an excuse to avoid vaccination.

Experts hope the community understands that preventing disease from the beginning is the best solution.

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *